Creative Medical Technology (CELZ) Competitors $5.40 -0.59 (-9.85%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.46 +0.06 (+1.11%) As of 02/21/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CELZ vs. EQ, BFRG, RLYB, SNYR, IXHL, CVM, COEP, MRNS, PMN, and CMMBShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Equillium (EQ), Bullfrog AI (BFRG), Rallybio (RLYB), Synergy CHC Corp. (Uplisting) (SNYR), Incannex Healthcare (IXHL), CEL-SCI (CVM), Coeptis Therapeutics (COEP), Marinus Pharmaceuticals (MRNS), ProMIS Neurosciences (PMN), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Equillium Bullfrog AI Rallybio Synergy CHC Corp. (Uplisting) Incannex Healthcare CEL-SCI Coeptis Therapeutics Marinus Pharmaceuticals ProMIS Neurosciences Chemomab Therapeutics Creative Medical Technology (NASDAQ:CELZ) and Equillium (NASDAQ:EQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Which has more volatility and risk, CELZ or EQ? Creative Medical Technology has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Equillium has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Do analysts prefer CELZ or EQ? Equillium has a consensus price target of $5.00, indicating a potential upside of 468.18%. Given Equillium's stronger consensus rating and higher possible upside, analysts clearly believe Equillium is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Equillium 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor CELZ or EQ? Creative Medical Technology received 35 more outperform votes than Equillium when rated by MarketBeat users. However, 83.72% of users gave Equillium an outperform vote while only 68.93% of users gave Creative Medical Technology an outperform vote. CompanyUnderperformOutperformCreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% EquilliumOutperform Votes3683.72% Underperform Votes716.28% Which has better valuation & earnings, CELZ or EQ? Creative Medical Technology has higher earnings, but lower revenue than Equillium. Equillium is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K945.00-$5.29M-$3.80-1.42Equillium$36.08M0.86-$13.34M-$0.14-6.29 Does the media favor CELZ or EQ? In the previous week, Creative Medical Technology had 3 more articles in the media than Equillium. MarketBeat recorded 3 mentions for Creative Medical Technology and 0 mentions for Equillium. Equillium's average media sentiment score of 1.00 beat Creative Medical Technology's score of -0.75 indicating that Equillium is being referred to more favorably in the news media. Company Overall Sentiment Creative Medical Technology Negative Equillium Positive Is CELZ or EQ more profitable? Creative Medical Technology has a net margin of 0.00% compared to Equillium's net margin of -10.05%. Equillium's return on equity of -20.68% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -63.05% -60.42% Equillium -10.05%-20.68%-10.77% Do insiders & institutionals have more ownership in CELZ or EQ? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 27.1% of Equillium shares are held by institutional investors. 2.8% of Creative Medical Technology shares are held by insiders. Comparatively, 30.3% of Equillium shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryEquillium beats Creative Medical Technology on 11 of the 18 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.47M$3.11B$5.84B$9.15BDividend YieldN/A1.55%4.75%3.85%P/E Ratio-1.4227.4925.4719.00Price / Sales945.00329.47447.5876.30Price / CashN/A168.8738.0134.83Price / Book0.723.687.644.62Net Income-$5.29M-$71.72M$3.18B$245.85M7 Day Performance13.92%-2.50%-1.99%-2.68%1 Month Performance119.51%-0.32%-0.42%-2.19%1 Year Performance28.57%-12.32%16.51%12.84% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.8967 of 5 stars$5.40-9.8%N/A+28.0%$10.47M$10,000.00-1.425Gap DownEQEquillium2.7177 of 5 stars$0.93-1.2%$5.00+438.8%-64.8%$32.60M$36.08M-6.5740Positive NewsBFRGBullfrog AI0.2578 of 5 stars$3.73+1.8%N/A-32.1%$32.10M$60,000.00-4.344RLYBRallybio2.45 of 5 stars$0.77+2.2%$9.75+1,166.2%-58.1%$31.95MN/A-0.4840SNYRSynergy CHC Corp. (Uplisting)N/A$3.65-1.4%$10.00+174.0%N/A$31.76MN/A0.0040Negative NewsGap UpIXHLIncannex Healthcare0.5562 of 5 stars$1.80+0.8%N/A-74.4%$31.66M$10,000.00-1.293Earnings ReportCVMCEL-SCIN/A$0.43+1.9%N/A-81.5%$31.50MN/A-0.8343News CoverageCOEPCoeptis Therapeutics0.5506 of 5 stars$12.67+1.8%N/A+7.5%$30.41MN/A-2.182News CoverageMRNSMarinus Pharmaceuticals4.2216 of 5 stars$0.55-0.2%$4.79+771.6%-94.4%$30.32M$30.99M-0.22110Analyst ForecastPMNProMIS Neurosciences0.3552 of 5 stars$0.91-4.2%N/A-62.4%$29.75MN/A-9.105News CoverageCMMBChemomab Therapeutics2.9666 of 5 stars$2.01+2.3%$7.50+274.1%+153.0%$28.79MN/A-2.0120Analyst ForecastNews Coverage Related Companies and Tools Related Companies Equillium Alternatives Bullfrog AI Alternatives Rallybio Alternatives Synergy CHC Corp. (Uplisting) Alternatives Incannex Healthcare Alternatives CEL-SCI Alternatives Coeptis Therapeutics Alternatives Marinus Pharmaceuticals Alternatives ProMIS Neurosciences Alternatives Chemomab Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELZ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts